Please check your internet connection and try again.
# Sompraz HP (Pantoprazole HP)
## Overview
Sompraz HP is a combination product containing pantoprazole, an acid suppressant, and antibiotics (typically amoxicillin and clarithromycin) used for the eradication of *Helicobacter pylori*. Pantoprazole is a proton pump inhibitor (PPI).
## Primary Indications
Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease or a history of peptic ulcer disease.
## Adult Dosing
The typical regimen is one kit taken twice daily for 10-14 days. Each kit usually contains:
* Pantoprazole 40 mg delayed-release tablet
* Amoxicillin 500 mg capsule
* Clarithromycin 500 mg tablet
Dosing should be taken as prescribed by the healthcare provider, usually before a meal.
## Pediatric Dosing
Dosing for pediatric patients is not well-established and should be determined by a specialist.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment, as the systemic exposure of pantoprazole is generally not significantly altered. However, caution may be advised in severe hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of hypersensitivity to penicillin.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia) associated with long-term PPI use.
* Concurrent use with rifampin or St. John's Wort (due to potential impact on pantoprazole levels).
* Concurrent use with cisapride, ergotamines, or pimozide (due to potential risk of QT prolongation with clarithromycin).
## Adverse Effects
**Common:** Diarrhea, nausea, abdominal pain, headache, dizziness, taste disturbance.
**Less Common/Serious:**
* **Pantoprazole:** Clostridium difficile-associated diarrhea, bone fractures (with long-term use), hypomagnesemia, vitamin B12 deficiency (with long-term use), lupus erythematosus, acute interstitial nephritis.
* **Amoxicillin:** Hypersensitivity reactions (including anaphylaxis), rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, hemolytic anemia.
* **Clarithromycin:** QT prolongation, *C. difficile*-associated diarrhea, hepatotoxicity, myopathy, pancreatitis.
## Key Drug Interactions
* **Pantoprazole:** Can decrease the absorption of drugs that require acidic gastric pH (e.g., ketoconazole, itraconazole, iron salts, vitamin B12). Can increase the levels of drugs metabolized by CYP2C19 (e.g., clopidogrel - though clinical significance is debated) and CYP3A4.
* **Clarithromycin:** Potent inhibitor of CYP3A4. May increase serum concentrations of numerous drugs including statins (risk of myopathy), colchicine, warfarin, theophylline, benzodiazepines, and certain antiretrovirals. Can prolong QT interval and should not be used with cisapride, pimozide, or ergotamine alkaloids.
## Monitoring
* Monitor for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms).
* Monitor for adverse effects of all components.
* For long-term pantoprazole use, monitor magnesium levels and consider bone density assessment.
* Monitor for signs of hypersensitivity reactions.
## Clinical Pearls
* Ensure the full course of therapy is completed to maximize eradication rates and minimize resistance.
* Patients should be advised to take pantoprazole before meals.
* Antibiotic resistance is a growing concern; adherence to prescribed regimens is crucial.
* Consider alternative treatment regimens for patients with penicillin allergy or clarithromycin resistance.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines for complete details, including specific contraindications, warnings, precautions, and drug interactions. This information does not replace clinical judgment.*
